anonymous
Guest
anonymous
Guest
you made the news
Yes.
.81 cents a share.
Mask up.
Smells like a dog.
you made the news
Things are CLEARly looking up here, the latest quarterly will support the momentum and provide clarity into the timing of the 300m cash infusion. Can’t help but be optimistic based on the momentum and fiscal outlook.
DS is going to have to cough up the dough. Plan on getting cash before EOY. Stable outlook going forward as the momentum builds. SOV is paramount to ongoing success. Expansion warranted as provider impressions carry more weight with outcomes data. ‘24 is our break out year.
CafePharma is how you prepare for an interview? You’re a moron.Wow, I started digging through this site as I’m preparing to interview with the company. There seems to be a whole lot of dysfunction here. I’m not sure if that’s emanating from one individual or perhaps there’s a more systemic issue behind this? Bizarre.
Shut up, stupid.No dumb ass, I didn’t say this is how I’m preparing for the interview. If you are indicative of the type of dick weed that is here I don’t think I have any interest in joining. Toxic.
No dumb ass, I didn’t say this is how I’m preparing for the interview. If you are indicative of the type of dick weed that is here I don’t think I have any interest in joining. Toxic.
No dumb ass, I didn’t say this is how I’m preparing for the interview. If you are indicative of the type of dick weed that is here I don’t think I have any interest in joining. Toxic.
Ignore this clown, they we not hired and for good reason. They spend their days trying to bash the company. Very childish.Smartest decision you've ever made. Things aren't good here and it's like watching a bus go over a cliff.
Ignore this clown, they we not hired and for good reason. They spend their days trying to bash the company. Very childish.
Dude, you need help.Stock closed at .74 cents. How is that some person on cafepharmas fault? Just ask the recruiters what they think of Esperion after they had all their candidates lied to and used in 2020. What goes around comes around and this is dead on to what happened with Esperion.
Sure, Karen.Stock closed at .74 cents. How is that some person on cafepharmas fault? Just ask the recruiters what they think of Esperion after they had all their candidates lied to and used in 2020. What goes around comes around and this is dead on to what happened with Esperion.
Sure, Karen.
Good call, Karen.The Scientific Hired, Highly Tenured Customer Facing Team and Lipid Trained Experts can't even move BA.
The money being wasted on ESPR is astounding.